Orginpulse Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 16-11-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.94 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Net Worth -3312.65%
(FY 2023)
- Total Assets 104.73%
(FY 2023)
About Orginpulse Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹2.94 Cr.
Kosuri Varma, Venkatesh Pandi, Galibsaheb Valluri, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230TG2021PTC152356
- Company No.
152356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Orginpulse Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kosuri Varma  | Additional Director | 09-Nov-2022 | Current |
| Venkatesh Pandi | Additional Director | 15-Jul-2024 | Current |
| Galibsaheb Valluri | Additional Director | 09-Nov-2022 | Current |
| Ranjithreddy Namireddy | Director | 18-Jun-2021 | Current |
| Poojitha Keesara | Director | 18-Jun-2021 | Current |
| Devendra Mandapati | Additional Director | 15-Jul-2024 | Current |
Financial Performance of Orginpulse Pharmaceuticals.
Orginpulse Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 3312.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Orginpulse Pharmaceuticals?
Unlock access to Orginpulse Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Noah Therapeutics Private LimitedInactive For E-Filing 7 months 30 days
Venkatesh Pandi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 May 2024 | ₹9.50 M | Open |
Others Creation Date: 03 Oct 2022 | ₹1.99 Cr | Open |
How Many Employees Work at Orginpulse Pharmaceuticals?
Orginpulse Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orginpulse Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orginpulse Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
